German Bionic
Augsburg
About German Bionic
German Bionic is backed by renowned international technology investors such as Samsung Catalyst Fund, Storm Ventures, and MIG, which is also invested in Covid-19 vaccine developer BioNTech. The company and its products are regularly featured in top-tier publications and are the recipients of numerous awards, including the German Entrepreneur Award, the Land of Ideas Award, the Automatica Award, as well as a nomination for Hannover Messe’s coveted Hermes Award. The German Bionic Cray X is the world’s first connected exoskeleton. Linked to the Smart Factory, it self-learns to reinforce lifting movements and prevent incorrect posture, thus becoming an intelligent link between humans and machines. In doing so, it delivers data that underscores its ability to protect the health of workers, measurably reduce the risk of accidents, and thereby make quantifiable improvements to work processes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $64.5M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2023)
- Website: germanbionic.com
- Phone: +49-0821-9074-9780
Industries & Categories
Artificial Intelligence (AI), Manufacturing, Public Safety, Robotics, Wearables
Social Profiles
Canonical: https://fsome.com/organization/german-bionic-43408 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.